Table 2

Surgeons’ indications for and contraindications to the use of intra-articular steroid hip injection (IASHI]

Survey questionGroup of surgeons by years of experience; no. (and %) of surgeons
< 5 yr
n = 11
5–10 yr
n = 24
> 10 yr
n = 64
Total
n = 99
1. What are your indications for hip injection? (check all that apply)
 Diagnostic, e.g., to sort out hip versus spine issue10 (90.9)21 (87.5)50 (78.1)81 (81.8)
 Therapeutic — relief of pain9 (81.8)13 (54.2)43 (67.2)65 (65.7)
 Patient not ready for surgery7 (63.6)8 (33.3)33 (51.6)48 (48.5)
 Therapeutic — while waiting for arthroplasty8 (72.7)8 (33.3)26 (40.6)42 (42.4)
 Patient can’t take arthritis pills6 (54.5)5 (20.8)30 (46.9)41 (41.4)
 No success from other treatments (i.e., physiotherapy, pills)5 (45.5)4 (16.7)21 (32.8)30 (30.3)
 Patient specifically requests procedure3 (27.3)5 (20.8)19 (29.7)27 (27.3)
 Mainly used as an addition to other treatments4 (36.4)4 (16.7)19 (29.7)27 (27.3)
 Mainly used after other treatments failed3 (27.3)5 (20.8)18 (28.1)26 (26.3)
 Consider it as one primary arthritis-treatment option01 (4.2)1 (1.6)2 (2.0)
*Did not list any indications7 (7.1)
2. Would you offer steroid hip injection more often, with the following types of arthritis:
(a) Rheumatoid hip arthritis
  Inject more often4 (36.4)6 (25.0)10 (15.6)20 (20.2)
  Inject less often2 (18.2)08 (12.5)10 (10.1)
  This factor would not change my management4 (36.4)17 (70.8)42 (65.6)63 (63.6)
  *Did not answer1 (9.1)1 (4.1)4 (6.2)6 (6.1)
(b) Osteoarthritis of the hip
  Inject more often2 (18.2)010 (15.6)12 (12.1)
  Inject less often1 (9.1)08 (12.5)9 (9.1)
  This factor would not change my management8 (72.7)19 (79.2)42 (65.6)69 (69.7)
  *Did not answer05 (20.8)4 (6.2)9 (9.1)
(c) Avascular necrosis
  Inject more often002 (3.1)2 (2.0)
  Inject less often5 (45.5)6 (25.0)34 (53.1)45 (45.5)
  This factor would not change my management5 (45.5)16 (66.7)24 (37.5)45 (45.5)
  *Did not answer1 (9.1)2 (8.3)4 (6.2)7 (7.1)
(d) If you suspect an effusion of the hip joint
  Inject more often2 (18.2)1 (4.2)22 (34.4)25 (25.3)
  Inject less often04 (16.7)12 (18.8)16 (16.2)
  This factor would not change my management1 (9.1)17 (70.8)25 (39.1)43 (43.4)
  *Did not answer8 (72.7)2 (8.3)5 (7.8)15 (15.2)
3. Type of radiographic findings; would you offer IASHI more often when (check all that apply)
 Mild arthritis9 (81.8)13 (54.2)34 (53.1)56 (56.6)
 Cystic changes on radiographs04 (16.7)13 (20.3)17 (17.2)
 Severe joint-space narrowing1 (9.1)4 (16.7)12 (18.8)17 (17.2)
 Case with few or no osteophytes3 (27.3)1 (4.2)11 (17.2)15 (15.2)
4. Repeat injection:
(a) Would you give a second injection if the first one went well and the patient was agreeable?11 (100)16 (66.7)49 (76.6)76 (76.8)
(b) How long would you advise waiting before a second injection?
  1–2 mo0/110/164/49 (8.2)4/76 (5.3)
  3–6 mo10/11 (90.9)14/16 (87.5)40/49 (81.6)64/76 (84.2)
  > 6 mo1/11 (9.1)1/16 (6.3)4/49 (8.2)6/76 (7.9)
  *Did not specify time period0/111/16 (6.3)1/49 (2.0)2/76 (2.6)
5. IASHI and age of the patient with hip arthritis:
 Especially useful in a very young patient (< 40 yr)2 (18.2)5 (20.8)11 (17.2)18 (18.2)
 Especially useful in a very old patient (> 85 yr)05 (20.8)12 (18.8)17 (17.2)
 Age would not strongly influence my decision9 (81.8)12 (50.0)36 (56.3)57 (57.6)
*Did not answer02 (8.3)5 (7.8)7 (7.1)
6. Do you feel there are reasons not to have IASHI? (open-ended question)
 Active infection or infection risk3 (27.3)14 (58.3)24 (37.5)41 (41.4)
 Advanced/severe osteoarthritis2 (18.2)2 (8.3)5 (7.8)9 (9.1)
 Allergy1 (9.1)3 (12.5)3 (4.7)7 (7.1)
 Obesity1 (9.1)1 (4.2)2 (3.1)4 (4.0)
 Radiology unavailable003 (4.7)3 (3.0)
 Avascular necrosis002 (3.1)2 (2.0)
 Upcoming hip surgery01 (4.2)1 (1.6)2 (2.0)
 Age (not useful for young person)002 (3.1)2 (2.0)
 Surgeons stating no contraindications to IASHI01 (4.2)1 (1.6)2 (2.0)
*No contraindications listed28 (28.3)
  • * For each question, if the nonresponse rate was greater than 5%, then the nonresponse rate is listed as a separate row.